推荐产品
生物来源
rabbit
质量水平
抗体形式
purified antibody
抗体产品类型
primary antibodies
克隆
polyclonal
种属反应性
human, mouse
制造商/商品名称
Upstate®
技术
western blot: suitable
同位素/亚型
IgG
运输
dry ice
靶向翻译后修饰
unmodified
一般描述
对称二甲基化精氨酸(sDMA)是翻译后修饰精氨酸甲基化的产物。sDMA是不对称二甲基精氨酸的结构异构体。
特异性
约16 kDa处的SmD3和其他含有对称二甲基化精氨酸的蛋白质
免疫原
一种对应于小核糖核蛋白Smd3的99-119位氨基酸的肽。
应用
对称抗二甲基精氨酸抗体(SYM11)已用于:
- 免疫共沉淀
- 蛋白质印迹分析
- 免疫沉淀
生化/生理作用
对称二甲基精氨酸(sDMA)是精氨酸转运的竞争对手,通过肾脏排泄被消除。sDMA作为指示估计肾小球滤过率(GFR)和冠状动脉疾病(CAD)严重程度的标志物。sDMA升高与心血管疾病和死亡率的风险相关。它也可能有助于早期发现慢性肾脏疾病。sDMA是肾功能的内源性标志物。它与肿瘤发生有关。
质量
通过免疫印迹对Jurkat细胞的RIPA裂解液进行了常规评估
目标描述
~16 kDa
外形
形式:纯化
分析说明
对照
阳性抗原对照:目录# 12-303,Jurkat细胞裂解液。
阳性抗原对照:目录# 12-303,Jurkat细胞裂解液。
法律信息
UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany
未找到合适的产品?
试试我们的产品选型工具.
储存分类代码
10 - Combustible liquids
WGK
WGK 1
Microbiology spectrum, 11(6), e0290623-e0290623 (2023-10-26)
PRMT5 contributes to secondary metabolite biosynthesis in Ganoderma lucidum. However, the mechanism through which PRMT5 regulates the biosynthesis of secondary metabolites remains unclear. In the current study, PRMT5 silencing led to a significant decrease in the biosynthesis of polysaccharides from
Communications biology, 7(1), 241-241 (2024-02-29)
PRMT5, a type II arginine methyltransferase, is involved in transcriptional regulation, RNA processing and other biological processes and signal transduction. Secondary metabolites are vital pharmacological compounds in Ganoderma lucidum, and their content is an important indicator for evaluating the quality
Nature communications, 8(1), 1305-1305 (2017-11-05)
Piwi-interacting RNAs (piRNAs) and PIWI proteins play a crucial role in germ cells by repressing transposable elements and regulating gene expression. In Drosophila, maternal piRNAs are loaded into the embryo mostly bound to the PIWI protein Aubergine (Aub). Aub targets
EMBO reports, 16(3), 379-386 (2015-01-21)
Germ cells give rise to all cell lineages in the next-generation and are responsible for the continuity of life. In a variety of organisms, germ cells and stem cells contain large ribonucleoprotein granules. Although these particles were discovered more than
Journal of medicinal chemistry, 65(3), 1749-1766 (2022-01-19)
The PRMT5•MTA complex has recently emerged as a new synthetically lethal drug target for the treatment of MTAP-deleted cancers. Here, we report the discovery of development candidate MRTX1719. MRTX1719 is a potent and selective binder to the PRMT5•MTA complex and
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门